Hyperpolarized 13C-pyruvate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Hyperpolarized 13C-pyruvate, covering 2025-07-23 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer [Phase 2]